Brief: Pacific Biosciences of California Q3 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.22
07/11/2024 21:05
Nov 07 (Reuters) - Pacific Biosciences of California Q3 adjusted gross profit USD 13 million. * Q3 adjusted net income USD -46 million vs. IBES estimate USD -63.8 million * Q3 revenue USD 40 million vs. IBES estimate USD 42 million * Q3 EPS USD -0.22
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview